D-1485-2014 Class III Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-1485-2014 was initiated by Pfizer Inc. on Jun 19, 2014 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant. The recall status is terminated (terminated Jun 3, 2015). Affected quantity: 22,461 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 6, 2014
Initiation Date
Jun 19, 2014
Termination Date
Jun 3, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,461 bottles

Product description

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30

Reason for recall

Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.

Distribution pattern

Nationwide (Continental USA and Puerto Rico). A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market. One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope. Only the product distributed within US/PR market (bottles) is in the scope of this recall.

Code information

Lot # V130822; Exp 01/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1485-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1485-2014. Report a data issue: hello@regdatalab.com.